These considerations in fact arise from contrasting evidences about the association between liver fibrosis and IR observed in some studies on patients with CHC [4], [9] or CHB [10], and from the evidences that insulin-sensitizer therapies obtain an improvement in histological outcomes in a proportion of NAFLD patients only [11], [12]. Here, INS is linked to Hepatic fibrosis.